|Bid||15.74 x 1000|
|Ask||15.88 x 1000|
|Day's Range||15.74 - 15.82|
|52 Week Range||9.83 - 18.78|
|Beta (5Y Monthly)||1.17|
|PE Ratio (TTM)||20.71|
|Forward Dividend & Yield||2.67 (17.18%)|
|Ex-Dividend Date||Aug 03, 2020|
|1y Target Est||N/A|
New Enterprise Associates revealed a large investment in biopharmaceutical company Metacrine. Baker Brothers Advisors disclosed an initial position in oncology-focused biopharmaceutical firm of Prelude.
In the latest trading session, Sprague Resources (SRLP) closed at $15.05, marking a -0.73% move from the previous day.
Is (SRLP) Outperforming Other Oils-Energy Stocks This Year?